C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2006
03/21/2006	US7015308 human Desert hedgehog protein of given sequence; a drug target: efficacy in elucidation of hereditary morphological abnormalities in humans to establish their treatments and diagnoses
03/21/2006	US7015205 Melanoma vaccine and methods of making and using same
03/21/2006	US7015192 synthetic hexapeptides or oligopeptides used as neurosecretion antagonists; bloking release of catecholamines; wrinkling and aging resistance
03/21/2006	US7015039 Separating the epithelium and the stroma of a cornea by providing a solution that includes a detaching agent diluted in a culture medium, solution is then applied to the surface of the cornea; solution with reduced cytotoxicity
03/21/2006	US7015038 Preparing container with a scaffold; placing cell suspension into container to distribute cells onto scaffold; connecting container to a reservoir to drive medium into container; promoting up-and-down medium level motion for cultivation
03/21/2006	US7015037 Multiponent adult stem cells and methods for isolation
03/21/2006	US7015036 Human liver cell line
03/21/2006	US7015035 RD114-based retroviral packaging cell line and related compositions and methods
03/21/2006	US7015034 Materials and procedures for the purification of cells
03/21/2006	US7015032 A micropropagation system for automatically growing plant tissues which makes use of an intermittent exposure to a liquid nutrient solution
03/21/2006	US7015024 Compositions containing recombinant poxviruses having foreign DNA expressed under the control of poxvirus regulatory sequences
03/21/2006	US7015019 1-O-L-arginyl ester 3-O-monoacyl glycerides and 1-O-L-arginyl ester 2,3-O-diacyl glycerides type surface active agents
03/21/2006	US7015015 Nucleotide sequences coding polypeptide for use in treatment of diabetes, epilepsy, depression, ischemia and muscle disorders
03/21/2006	US7015008 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding
03/21/2006	US7015007 Contacting a sample with an isolated monoclonal antibody that binds to a substantially-pure coagulase-negative Staphylococcus epidermidis capsular polyssocharide adhesin antigen that binds to polymeric material, wherein said adhesin antigen inhibits binding to polymeric material
03/21/2006	US7015001 Comprises nucleotide sequences coding spinosyn-A biosynthetic enzyme for preparing pesticides; biological pest control agents
03/21/2006	US7014993 DNA encoding a Tumor Antigen Derived Gene-14 (TADG-14) protein
03/21/2006	US7014991 Use of injectable dyes for staining an anterior lens capsule and vitreo-retinal interface
03/21/2006	US7014853 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
03/21/2006	US7014849 Keratinocyte culture and uses thereof
03/21/2006	CA2154080C Novel anticoagulant cofactor activity
03/21/2006	CA1341502C Method for the production of erythropoietin
03/17/2006	CA2482045A1 Method of cryopreserving cells
03/16/2006	WO2006029347A2 Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
03/16/2006	WO2006029262A2 Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
03/16/2006	WO2006029198A2 Culturing human embryonic stem cells
03/16/2006	WO2006029197A1 Medium and culture of embryonic stem cells
03/16/2006	WO2006029093A1 Common marmoset embryonic stem cell lines
03/16/2006	WO2006029084A2 Bone marrow derived oct3/4+ stem cells
03/16/2006	WO2006029010A2 Methods of activating nkt cells
03/16/2006	WO2006028723A1 Non-embryonic totipotent blastomer-like stem cells and methods therefor
03/16/2006	WO2006028278A1 Method of in-vitro proliferation of androgenetic line stem cell
03/16/2006	WO2006028274A1 Production of cell culture product and material for use in said production
03/16/2006	WO2006028202A1 Adsorbent for lymphocyte proliferation inhibitor and treating method
03/16/2006	WO2006028197A1 Anti-a33 antibody
03/16/2006	WO2006028049A1 Method of producing adaptation medium for astrocyte-like cells
03/16/2006	WO2006027545A2 Method
03/16/2006	WO2006027229A1 Scalable process for cultivating undifferentiated stem cells in suspension
03/16/2006	WO2006026992A1 Altered structure of n-glycans in a fungus
03/16/2006	WO2005123909A3 Isolation and characterization of muscle regenerating cells
03/16/2006	WO2005118874A9 Enhancing protein expression
03/16/2006	WO2005118778A3 Method for ex vivo isolating and expanding human cornea stem cells and uses thereof
03/16/2006	WO2005103232A3 Isolation and culture of a high purity population of cone photoreceptor cells by tissue dissociation and pna-panning, and biological applications thereof
03/16/2006	WO2005103076A3 Erythropoietin protein variants
03/16/2006	WO2005100553A3 Method for assessment of cytotoxic lymphocyte activity
03/16/2006	WO2005081721A3 Method for enhancing transport of semiconductor nanocrystals across biological membranes
03/16/2006	WO2005063817A3 Methods for identifying functional antibodies
03/16/2006	WO2005038029A3 Luciferase biosensor
03/16/2006	WO2005021723A3 Nucleic acid molecules from rice controlling abiotic stress tolerance
03/16/2006	WO2004000220A3 Methods for purifying viral particles for gene therapy
03/16/2006	US20060059589 Soybean transformation method
03/16/2006	US20060059587 Plastidial-targeting peptide
03/16/2006	US20060059586 Plants with delayed flowering
03/16/2006	US20060059584 Method for the production of $g(b)-carotinoids
03/16/2006	US20060059583 Produced from Polypedilum vanderplanki larvae; introduction of these genes into animal cells successfully conferred desiccation resistance to the cells.
03/16/2006	US20060059576 Treatment of neurodegenerative conditions with nimesulide
03/16/2006	US20060058516 Novel serine-threonine kinase
03/16/2006	US20060058512 Process for producing humanized chimera antibody
03/16/2006	US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/16/2006	US20060058258 Gene transcription and ionizing radiation: methods and compositions
03/16/2006	US20060058234 VEGF traps and therapeutic uses thereof
03/16/2006	US20060058189 Ftsz-polypeptides as a target for herbicidal compounds
03/16/2006	US20060057723 Transgenic plants containing molecular decoys that alter protein content therein
03/16/2006	US20060057722 Conditioned medium of autologous or allogenic progenitor cells for angiogenesis treatment
03/16/2006	US20060057721 Identifying agents which modulate cell death, indicated by the expression of caspase-2 and/or caspase-7, in Glial cell line-derived neurotrophic factor (GDNF) family growth factor deprived neuronal or nonneuronal cells
03/16/2006	US20060057720 Mesenchymal cells derived from human embryonic stem cells
03/16/2006	US20060057718 Stem cell and progenitor cell expansion
03/16/2006	US20060057717 Human bone accessory cells
03/16/2006	US20060057716 Human malignant cystosarcoma phyllodes derived mouse cell line
03/16/2006	US20060057715 Methods and kits for isolating sperm cells
03/16/2006	US20060057712 Incubator and cell culturing method
03/16/2006	US20060057694 Rat receptor tyrosine knase, kdr
03/16/2006	US20060057693 Methods of treatment using electromagnetic field stimulated stem cells
03/16/2006	US20060057679 RAGE protein derivatives
03/16/2006	US20060057662 Membrane scaffold proteins
03/16/2006	US20060057657 Stem cell selection and differentiation
03/16/2006	US20060057645 Novel genes
03/16/2006	US20060057640 Using receptor tyrosine phosphatases as tools in identifying modulators for prevention and treatment of nervous system, cell proliferative and respiratory system disorders
03/16/2006	US20060057632 Artificial antibody library with super-repertory
03/16/2006	US20060057602 related to testes-specific, vespid and pathogenic proteins (RTVP); metastatic prostatic neoplasia
03/16/2006	US20060057588 Method of separating tumor cells with and without lymphotropic metastatic potential in a human carcinoma
03/16/2006	US20060057579 Method for predicting a drug transport capability by abcg2 polymorphisms
03/16/2006	US20060057542 Bone regeneration
03/16/2006	US20060057164 Isolated, purified polynucleotides, expression vector, host cells, antibodies; mutation functionally disrupting catalytic domain
03/16/2006	US20060057146 Selective targeting of tumor vasculature using antibody molecules
03/16/2006	US20060057139 Process for producing humanized chimera antibody
03/16/2006	US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides
03/16/2006	US20060057129 Preloaded dendritic cell vaccines for treating cancer
03/16/2006	US20060057125 Liver stromal cells for prevention and treatment of immune responses in transplantation
03/16/2006	US20060057124 Methods and compositions for culturing cardiomyocyte-like cells
03/16/2006	US20060057123 Method of inducing memory B cell development and terminal differentiation
03/16/2006	US20060057122 Functional assessment, specific enrichment and specific depletion of alloreactive human T cells
03/16/2006	US20060057121 Compositions and treatments using ex vivo activated cells for myelosuppressed patients
03/16/2006	US20060057120 Administration of dendritic cells partially matured in vitro for the treatment of tumors
03/16/2006	US20060057119 Biologic skin repair and enhancement
03/16/2006	US20060057117 Vascular endothelial growth factor 2
03/16/2006	US20060057116 Recombinant influenza viruses for vaccines and gene therapy
03/16/2006	US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
03/16/2006	US20060057072 Method for diagnosis and treatment of vascular disease
03/16/2006	CA2595137A1 Scalable process for cultivating undifferentiated stem cells in suspension

1 ... 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 ... 1827